A Crossover Study to Evaluate the Efficacy of Simvastatin in Elevating HDL-C Levels in Patients With Type 2 Diabetes (0733-216)(COMPLETED)

HDL Cholesterol Clinical Trial

Official title:
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Balanced, Three-Way Crossover Study to Evaluate the Efficacy of Simvastatin Therapy in Elevating HDL-C Levels in Patients With Type 2 Diabetic Dyslipidemia and Low HDL-C

Status Completed

Clinical Trial Summary

The purpose of this study is to see how well simvastatin raises HDL levels in patients with Type 2 Diabetes.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

HDL Cholesterol

Clinical Trial Details

NCT number	NCT00389896
Study type	Interventional
Source	Organon and Co
Contact
Status	Completed
Phase	Phase 3
Start date	July 26, 2001
Completion date	October 4, 2002

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02554604` - Identifying HDL Composition and Function in Preeclamptic and Normal Pregnancies
Active, not recruiting	`NCT00238004` - The Low HDL On Six Weeks Statin Therapy (LOW) Study	Phase 4
Recruiting	`NCT00736463` - Crossover of Higher Dose Statins in Patients With Low High-density Lipoproteins Cholesterol (HDLc)	Phase 4
Completed	`NCT00765284` - Effect of Niaspan on Cholesterol in Men	N/A
Completed	`NCT00809068` - High-density Lipoprotein (HDL) Cholesterol in Women Taking Tibolone	Phase 4